HUIYU PHARMACEUTICAL
68855310.454.60% ( +0.46 )
Q1 2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: HUIYU PHARMACEUTICAL(688553) the Revenue is 269.21 M (+12.61%);the EBIT is 40.79 M (+35.46%);the EPS is 0.0338 (+183.5%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.27B12.61%
----
----
EBIT
0.04B35.46%
----
----
EPS
0.0338183.46%
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf